Rochester, NY 6/16/2009 1:33:17 AM
Afternoon Gainers NASDAQ - GLUU,HAFC,LPTH - Sourced WhisperFromWallStreet.com
Glu Mobile Inc. - Hanmi Financial Corp - Cyclacel Pharmaceuticals, Inc.
Afternoon Gainers NASDAQ - GLUU,HAFC,LPTH - Sourced WhisperFromWallStreet.com
WhisperfromWallStreet.com is an award winning newsletter that specializes in sending alerts to our subscribers on stocks we think are going to run, why we think so, and teaching you how to become a better trader. We can now even deliver this information instantly to our "Penny Stock Alert" gadget that sits right on your Microsoft Vista or iGoogle desktop. You will know from the instant you get your confirmation email that we are different. What do you have to lose except a little time and a chance to really learn how to make money trading.
Sign up for our FREE alerts at WhisperfromWallStreet.com
---
Glu Mobile Inc.,GLUU
1.43 Up 0.21 (17.70%) 2:07pm ET
Glu Mobile Inc. designs, markets, and sells games for mobile phones worldwide. The company's games based on licensed intellectual property include Call of Duty, Deer Hunter, Diner Dash, Family Feud, The Dark Knight, Transformers, World Series of Poker, and Zuma; and original games based on its own intellectual property include Bonsai Blast, Get Cookin', Brain Genius, My Hangman, Space Monkey, Stranded, and Super K.O. Boxing. It sells its products through wireless carriers and other distributors. The company was formerly known as Sorrent, Inc. and changed its name to Glu Mobile Inc. in May 2005. Glu Mobile Inc. was incorporated in 2001 and is headquartered in San Mateo, California with additional offices in the United Kingdom, France, Germany, Spain, Italy, Poland, China, Brazil, Russia, Sweden, Chile, Canada, and Mexico.
Last Trade: 1.41
Day's Range: 1.25 - 1.66
52wk Range: 0.22 - 5.38
Volume: 455,837
---
Hanmi Financial Corporation,HAFC
1.72 Up 0.24 (16.22%) 2:21pm ET
Hanmi Financial Corp, which is struggling with liquidity and credit quality issues, said Leading Investment & Securities Co Ltd, a Korean securities broker-dealer, will invest up to $11 million of common equity capital in the company.
ABOUT
Hanmi Financial Corporation operates as the holding company for Hanmi Bank that provides general business banking products and services in the United States. It offers business and personal checking accounts, savings accounts, negotiable order of withdrawal accounts, money market accounts, and certificates of deposit. The company's loan portfolio includes real estate loans, such as commercial property, construction, and residential property loans; commercial and industrial loans comprising commercial term loans, commercial lines of credit, small business administration loans, and international trade finance; and consumer loans consisting of automobile loans, secured and unsecured personal loans, home improvement loans, home equity lines of credit, overdraft protection loans, and unsecured lines of credit and credit cards.
Last Trade: 1.71
Day's Range: 1.50 - 1.77
52wk Range: 0.75 - 6.77
Volume: 417,026
---
Here are a few alerts our WhisperfromWallStreet.com subscribers enjoyed.
SPNG 1000%
AMNG 241%
RKBD 300%
UTRM 169%
TLLE 266%
Sign up to receive free stock alerts
---
LightPath Technologies, Inc.,LPTH
Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Its orally-available drugs in clinical development include Sapacitabine (CYC682), an oral nucleoside analogue, which is in phase II studies for the treatment of hematological malignancies, such as acute myeloid leukemia in the elderly, myelodysplastic syndromes, cutaneous T-cell lymphoma, and lung cancer; Seliciclib (CYC202), a CDK (cyclin dependent kinase) inhibitor, which is in phase II studies for the treatment of lung cancer and nasopharyngeal cancer; and CYC116, an Aurora kinase and VEGFR2 inhibitor that is in phase I studies for patients with solid tumors.
Last Trade: 1.39
Day's Range: 1.22 - 1.40
52wk Range: 0.30 - 1.93
Volume: 57,014
---
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
WhisperfromWallStreet.com (WFWS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by WFWS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. WFWS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.whisperfromwallstreet.com or mentioned herein. WFWS may have been compensated with shares or with cash from third party shareholders or the company on behalf of one or more of the companies mentioned in this opinion.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WFWS undertakes no obligation to update such statements.
This is not a solicitation to buy or sell any securities. WhisperfromWallStreet.com, nor any of its affiliates are not registered investment advisors or a broker dealers. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
CONTACT: WhisperFromWallStreet.com
